胎儿TAPSE用于监测合并门体分流生长受限胎儿的心功能
研究纳入2018至2020年诊断的7例合并先天性门体分流(CPSS)的生长受限胎儿,每2周行胎儿TAPSE(f-TAPSE)及超声监测。全部病例见心脏增大,6/7例f-TAPSE在初诊及随访中高于第95百分位;出生后2例分流自发闭合,2例新生儿一过性高氨血症。作者认为f-TAPSE可作为评估心功能的实用超声工具,生长受限胎儿出现心脏增大时应专门评估胎儿门脉系统。
要点
- 生长受限胎儿出现心脏增大时,应专门行胎儿门脉系统超声评估以排查CPSS。
- 合并CPSS的生长受限胎儿中,f-TAPSE在初诊及随访时常高于第95百分位。
- f-TAPSE可作为合并CPSS的生长受限胎儿心功能评估与随访的附加超声指标。
核心结论
- 在同时诊断CPSS的生长受限胎儿中,f-TAPSE提供了评估心功能的实用超声工具,并可能作为随访的附加临床标记。
- 生长受限胎儿出现心脏增大应促使对胎儿门脉系统进行专门的超声评估。
研究设计与样本
- 研究组为2018至2020年间诊断的7例生长受限合并CPSS胎儿,每2周纵向随访。
- 每2周行超声胎儿TAPSE(f-TAPSE),每次随访记录估测胎儿体重、生物物理评分、无应激试验、多普勒血流指标及胎儿心胸指数。
- 出生后实验室与影像学检查从病历中调取。
关键影像表现/征象
- 诊断CPSS时平均孕周为32+1周。
- 全部病例均观察到心脏增大。
- 所有门体分流均分类为肝内型。
- 6/7例胎儿在初诊时及整个随访期间f-TAPSE值高于第95百分位。
- 分娩孕周介于36+5至38+5周。
诊断标准与关键数值
- f-TAPSE值高于第95百分位:6/7例胎儿在初诊时及整个随访期间符合。
临床应用与阅片要点
- 对生长受限胎儿应行胎儿门脉系统专门超声评估,尤其当发现心脏增大时。
- f-TAPSE可作为合并CPSS的生长受限胎儿心功能评估与随访的附加超声指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Congenital portosystemic shunt (CPSS) in a growth-restricted fetus may lead to cardiac overload and ultimately hemodynamic imbalance. The aim of the study was to describe the application of tricuspid annular plane systolic excursion (TAPSE) for surveillance of cardiac function in growth-restricted fetuses diagnosed with CPSS.
METHODS: The study group consisted of 7 fetuses with growth restriction diagnosed with CPSS between 2018 and 2020. Patients were followed longitudinally every 2 weeks. Sonographic fetal-TAPSE (f-TAPSE) was performed every 2 weeks. At each visit, the following parameters were recorded: estimated fetal weight, biophysical profile, nonstress test, Doppler flow indices, and fetal cardiothoracic index. Postnatal laboratory and imaging tests were retrieved from the medical files.
RESULTS: Mean gestational age at diagnosis of CPSS was 32 + 1 weeks. Cardiomegaly was observed in all cases. All portosystemic shunts were classified as intrahepatic. Values of f-TAPSE were above the 95th percentile in 6/7 fetuses at presentation and throughout follow-up. Gestational age at delivery ranged between 36 + 5 and 38 + 5 weeks. Postnatally, spontaneous closure of the shunt was noted in 2 infants. Transient hyperammonemia was diagnosed in 2 neonates, with no signs of the characteristic complication.
CONCLUSIONS: In growth-restricted fetuses diagnosed concomitantly with CPSS, f-TAPSE offers a practical sonographic tool for assessment of cardiac function and may serve as an additional clinical marker for follow-up. The appearance of cardiomegaly in growth-restricted fetuses should prompt a dedicated sonographic evaluation of the fetal portal system.
引用
- Bardin R, Perlman S, Hadar E, et al. Fetal-TAPSE for Surveillance of Cardiac Function in Growth-Restricted Fetuses With a Portosystemic Shunt. J Ultrasound Med. 2021. PMID: 33426710. doi:10.1002/jum.15629
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。